How is Mobile Technology Driving the Lab of the Future?

Researchers in today’s labs often find it challenging to capture data while running experiments. The fact that researchers need to move locations to record or transfer handwritten data can be, at the very least, inefficient and at worst, a way to introduce substantial error. This can ultimately lead to experimental failure.

LabTwin is hosting a roundtable-style webinar, where R&D IT leaders will discuss how mobile technology can overcome these pressing problems. Mobile apps can capture data from anywhere in the lab and automatically upload these data into laboratory informatics systems.

Mobile technology also allows scientists to access data and information, hands-free while working at the bench. The technology has the potential to enhance connectivity between data, devices, and people. In this webinar, you’ll see how the inevitable rise of mobile technology in the laboratory is starting to create the smart, integrated lab of the future and maximize R&D efficiency.

Speakers

John Egerton, Head of Sales, LabTwin

John joined LabTwin with over 15 years of leadership experience within the laboratory informatics industry. He helped some of the world’s largest life sciences organisations within all stages of drug discovery, development and manufacturing to modernise, streamline their laboratory workflows, accelerate outcomes and ensure compliance. At LabTwin, John helps customers accelerate research outcomes with the implementation of machine-learning and voice-powered technology.

Message Presenter

Margaret Porter Scott, Vice President, Biochemical & Cellular Pharmacology, Genentech

Dr. Margaret Porter Scott is currently Vice President of Biochemical and Cellular Pharmacology at Genentech.  She and her team bring expertise in quantitative in vitro assays and the mechanistic study of molecules to all of Genentech’s research programs.  Her team is also responsible for as bioanalytical and biotransformation assays for large molecule programs.   Previous to joining Genentech Margaret was Senior Director of Lead Discovery at Epizyme and was instrumental in delivering first-in-human inhibitors including the recently approved drug Tazemetostat for the treatment of epithelioid sarcoma.  Prior to Epizyme, Margaret had over a decade of training in drug discovery through her scientific positions at Millennium, Neogenesis, Vertex and Pfizer.  Margaret received her BA from Oberlin College and her PhD from SUNY Stony Brook.

Message Presenter

Sebastian Christ, Digital Lab Consultant, Bayer

Since his beginning at Bayer, Sebastian has been involved in improving scientific workflows with innovative IT technologies. With his background in chemistry, he bridged the collaboration between the IT department and the lab, building the Lab of the Future. As a Digital Lab Consultant, Sebastian is developing in house systems or cooperating with external partners to bring IoLT, Natural Language Processing and structured data into the Bayer labs.

Message Presenter